melanoma

green light go go ahead advance yes streetlight
Biotech

Moderna posts melanoma data behind decision to say 'I do' to IDO

Responses in melanoma patients failed by checkpoint inhibitors informed a decision to expand and prioritize development of the cancer candidate.
Nick Paul Taylor Oct 13, 2025 5:15am
Layoffs

IO lays off 50% after FDA derails cancer vaccine approval plan

Sep 29, 2025 8:55am
dominoes fall series fail

Krystal discontinues melanoma study after FDA's Replimune rebuff

Aug 21, 2025 10:50am
dart board miss failure

Cancer vaccine's 'narrow' fail won't stop IO heading to FDA

Aug 11, 2025 9:48am
arrow choose one big pick forward many

Scancell picks winner from phase 2 cancer vaccine face-off

Jul 22, 2025 9:38am
Image of a neon sign with the word no lit up next to an unlit yes

Replimune's request for melanoma approval rejected by FDA

Jul 22, 2025 8:45am